BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.70
+0.30 (1.02%)
Jul 14, 2026, 12:41 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 760.68 million as of July 14, 2026. Its market cap has decreased by -8.62% in one year.
Market Cap
760.68M
Enterprise Value
722.08M
Revenue
263.81M
Ranking
n/a
PE Ratio
17.60
Stock Price
29.70
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 760.68M, a decrease of -51.88%. That is a compound annual growth rate of -8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 760.68M | -4.19% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.02B |
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 978.96M |
| Meribank Biotech | 964.56M |
| Taiwan Advance Bio-Pharmaceutical | 891.90M |
| NatureWise Biotech & Medicals | 834.71M |
| MegaPro Biomedical | 737.82M |